---
annotation-target: ccid-14-1023.pdf
---


>%%
>```annotation-json
>{"created":"2022-08-08T02:46:37.337Z","updated":"2022-08-08T02:46:37.337Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":11,"end":125},{"type":"TextQuoteSelector","exact":"Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome","prefix":"%125%150%200%300%400%CASE REPORT","suffix":": A Case Report and Literature R"}]}]}
>```
>%%
>*%%PREFIX%%%125%150%200%300%400%CASE REPORT%%HIGHLIGHT%% ==Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome== %%POSTFIX%%: A Case Report and Literature R*
>%%LINK%%[[#^tq9dqvn47rd|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^tq9dqvn47rd


>%%
>```annotation-json
>{"created":"2022-08-08T02:47:02.503Z","updated":"2022-08-08T02:47:02.503Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":688,"end":861},{"type":"TextQuoteSelector","exact":"Sézary syndrome (SS) is a rare type of cutaneous T-cell lymphoma (CTCL) that is characterized by erythroderma, lymphadenopathy and circulating clonal T-cells (Sézary cells).","prefix":"e’s Republic of China Abstract: ","suffix":" However, to our knowledge, reac"}]}]}
>```
>%%
>*%%PREFIX%%e’s Republic of China Abstract:%%HIGHLIGHT%% ==Sézary syndrome (SS) is a rare type of cutaneous T-cell lymphoma (CTCL) that is characterized by erythroderma, lymphadenopathy and circulating clonal T-cells (Sézary cells).== %%POSTFIX%%However, to our knowledge, reac*
>%%LINK%%[[#^hzpw1ofvwsk|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^hzpw1ofvwsk


>%%
>```annotation-json
>{"created":"2022-08-08T02:47:24.525Z","updated":"2022-08-08T02:47:24.525Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":1160,"end":1234},{"type":"TextQuoteSelector","exact":"With complaints of recurrent skin symptoms and enlarged lymph nodes (LNs),","prefix":"n a 57-year-old female patient. ","suffix":" she was admitted to our center "}]}]}
>```
>%%
>*%%PREFIX%%n a 57-year-old female patient.%%HIGHLIGHT%% ==With complaints of recurrent skin symptoms and enlarged lymph nodes (LNs),== %%POSTFIX%%she was admitted to our center*
>%%LINK%%[[#^1h74ove8h43|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^1h74ove8h43


>%%
>```annotation-json
>{"created":"2022-08-08T02:47:51.443Z","updated":"2022-08-08T02:47:51.443Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":1452,"end":1623},{"type":"TextQuoteSelector","exact":" Typical Sézary cells were identified through  morphology  and  further  confirmed  by  flow  cytometric  immunophenotyping  in peripheral blood (PB) and bone marrow (BM).","prefix":"system commonly involved in LCH.","suffix":" In addition, T-cell receptor ge"}]}]}
>```
>%%
>*%%PREFIX%%system commonly involved in LCH.%%HIGHLIGHT%% ==Typical Sézary cells were identified through  morphology  and  further  confirmed  by  flow  cytometric  immunophenotyping  in peripheral blood (PB) and bone marrow (BM).== %%POSTFIX%%In addition, T-cell receptor ge*
>%%LINK%%[[#^pe3tiy4zjy7|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^pe3tiy4zjy7


>%%
>```annotation-json
>{"created":"2022-08-08T02:48:03.371Z","updated":"2022-08-08T02:48:03.371Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":1697,"end":1760},{"type":"TextQuoteSelector","exact":"e BRAF V600E gene mutation was negative in skin, LN, PB and BM.","prefix":"ge-ment was positive, whereas th","suffix":" The patient was ultimately diag"}]}]}
>```
>%%
>*%%PREFIX%%ge-ment was positive, whereas th%%HIGHLIGHT%% ==e BRAF V600E gene mutation was negative in skin, LN, PB and BM.== %%POSTFIX%%The patient was ultimately diag*
>%%LINK%%[[#^sh5u76vtkbb|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^sh5u76vtkbb


>%%
>```annotation-json
>{"created":"2022-08-08T02:48:55.517Z","updated":"2022-08-08T02:48:55.517Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":2204,"end":2663},{"type":"TextQuoteSelector","exact":"Cutaneous T-cell lymphomas (CTCLs) encompass a heterogeneous group of rare non- Hodgkin lymphomas initially arising from malignant T lymphocytes localized in the skin. Sézary syndrome (SS), which is the leukemic variant of mycosis fungoides (MF), accounts  for  approximately  5%  of  CTCLs.1  SS  is  more  aggressive  than  MF  and characterized by erythroderma, lymphadenopathy and circulating clonal T-cells with cerebriform nuclei, so-called Sézary cells","prefix":"angement, BRAF V600EIntroduction","suffix":". Although the presence of large"}]}]}
>```
>%%
>*%%PREFIX%%angement, BRAF V600EIntroduction%%HIGHLIGHT%% ==Cutaneous T-cell lymphomas (CTCLs) encompass a heterogeneous group of rare non- Hodgkin lymphomas initially arising from malignant T lymphocytes localized in the skin. Sézary syndrome (SS), which is the leukemic variant of mycosis fungoides (MF), accounts  for  approximately  5%  of  CTCLs.1  SS  is  more  aggressive  than  MF  and characterized by erythroderma, lymphadenopathy and circulating clonal T-cells with cerebriform nuclei, so-called Sézary cells== %%POSTFIX%%. Although the presence of large*
>%%LINK%%[[#^dyde5jwxsxj|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^dyde5jwxsxj


>%%
>```annotation-json
>{"created":"2022-08-08T02:51:06.195Z","updated":"2022-08-08T02:51:06.195Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":14230,"end":14694},{"type":"TextQuoteSelector","exact":"(A) Representative images  of Sézary cells in  peripheral blood  (original magnification×1000). (B) Representative scatter plots for peripheral blood; abnormal mature T lymphocytes were monoclonal (CD3dim+, CD5+, CD7+, CD4+, CD8-, CD45RO+, CD45RA-, TCRαβ+, TCRγδ-, CD10-, and cKi67-). (C) Representative scatter plots for bone marrow; abnormal mature T lymphocytes were monoclonal (CD3dim+, CD2+, CD7+, CD4+, CD8-, CD45RO+, CD45RA-, CD5+, TCRαβ+, TCRγδ-, and CD56-","prefix":" cytometric immunophenotyping.  ","suffix":").Table 1 Results of TCR Gene Re"}]}]}
>```
>%%
>*%%PREFIX%%cytometric immunophenotyping.%%HIGHLIGHT%% ==(A) Representative images  of Sézary cells in  peripheral blood  (original magnification×1000). (B) Representative scatter plots for peripheral blood; abnormal mature T lymphocytes were monoclonal (CD3dim+, CD5+, CD7+, CD4+, CD8-, CD45RO+, CD45RA-, TCRαβ+, TCRγδ-, CD10-, and cKi67-). (C) Representative scatter plots for bone marrow; abnormal mature T lymphocytes were monoclonal (CD3dim+, CD2+, CD7+, CD4+, CD8-, CD45RO+, CD45RA-, CD5+, TCRαβ+, TCRγδ-, and CD56-== %%POSTFIX%%).Table 1 Results of TCR Gene Re*
>%%LINK%%[[#^qlbhctwnixj|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^qlbhctwnixj


>%%
>```annotation-json
>{"created":"2022-08-08T02:52:12.833Z","updated":"2022-08-08T02:52:12.833Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":12961,"end":13227},{"type":"TextQuoteSelector","exact":" LCH is currently regarded as an inflam-matory  myeloid  neoplasia  due  to  the  clonal  expansion  of myeloid precursors and features involvement of one or multi-ple organs, such as the bone, skin, lung, LNs, thyroid, liver, spleen, BM, and central nervous system.","prefix":"y immunohis-tochemistry results.","suffix":"7 However, the skin manifestatio"}]}]}
>```
>%%
>*%%PREFIX%%y immunohis-tochemistry results.%%HIGHLIGHT%% ==LCH is currently regarded as an inflam-matory  myeloid  neoplasia  due  to  the  clonal  expansion  of myeloid precursors and features involvement of one or multi-ple organs, such as the bone, skin, lung, LNs, thyroid, liver, spleen, BM, and central nervous system.== %%POSTFIX%%7 However, the skin manifestatio*
>%%LINK%%[[#^1lwa71zfsme|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^1lwa71zfsme


>%%
>```annotation-json
>{"created":"2022-08-08T02:52:40.639Z","updated":"2022-08-08T02:52:40.639Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":13696,"end":13840},{"type":"TextQuoteSelector","exact":"evious studies have indicated that cyclinD1 is a useful immunohistochemical marker for differentiating  LCH  and  reactive  LC  proliferation.8,","prefix":" in LN, PB, skin or BM cells. Pr","suffix":"9 Negative expression of cyclinD"}]}]}
>```
>%%
>*%%PREFIX%%in LN, PB, skin or BM cells. Pr%%HIGHLIGHT%% ==evious studies have indicated that cyclinD1 is a useful immunohistochemical marker for differentiating  LCH  and  reactive  LC  proliferation.8,== %%POSTFIX%%9 Negative expression of cyclinD*
>%%LINK%%[[#^jfe0riwcfd|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^jfe0riwcfd


>%%
>```annotation-json
>{"created":"2022-08-08T02:59:09.295Z","updated":"2022-08-08T02:59:09.295Z","document":{"title":"CCID_A_323865 1023..1028","link":[{"href":"urn:x-pdf:bdccddd574d01a3b4c10d107c27b6352"},{"href":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf"}],"documentFingerprint":"bdccddd574d01a3b4c10d107c27b6352"},"uri":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","target":[{"source":"vault:/hematology-theroy/papers/yanxiaojing/ccid-14-1023.pdf","selector":[{"type":"TextPositionSelector","start":18020,"end":18190},{"type":"TextQuoteSelector","exact":"the same TCR-γ gene rearrangement was detected in the skin and PB cells, whereas the same TCR-β gene rearrangement was identified in the PB, BM and LN cells in our case. ","prefix":"oid misdiagnosis.Interestingly, ","suffix":"However, the same TCR gene rearr"}]}]}
>```
>%%
>*%%PREFIX%%oid misdiagnosis.Interestingly,%%HIGHLIGHT%% ==the same TCR-γ gene rearrangement was detected in the skin and PB cells, whereas the same TCR-β gene rearrangement was identified in the PB, BM and LN cells in our case.== %%POSTFIX%%However, the same TCR gene rearr*
>%%LINK%%[[#^1yuw32fryyt|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^1yuw32fryyt
